Skip to main content
H.R. 6102 116th Congress House

VALID Act of 2020

Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.

Introduced: March 5, 2020 Introduced by: Diana DeGette Democratic · Colorado See on congress.gov
Health Administrative law and regulatory proceduresAdministrative remediesAdvisory bodiesCongressional oversight
More subjectsShow fewer subjects
Department of Health and Human ServicesDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careFederal preemptionFood and Drug Administration (FDA)Government information and archivesHealth technology, devices, suppliesLicensing and registrationsMedical tests and diagnostic methodsPerformance measurementUser charges and fees
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 5, 2020
Referred to the House Committee on Energy and Commerce.
Mar 5, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 5, 2020

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020

This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).

 Related & companion bills 2
  • S 3404 Identical bill VALID Act of 2020
  • HR 4128 Reintroduced Bill VALID Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6102: VALID Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6102/
MLA
"H.R. 6102: VALID Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6102/.
Bluebook (legal)
H.R. 6102, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6102/.
Markdown link
[H.R. 6102: VALID Act of 2020](https://openamerica.io/bill/116-HR-6102/)
Report a problem